Many articles have summarized the changing epidemiology of Clostridium difficile infections (CDI) in humans, but the emerging presence of C. difficile in foods and animals and possible measures to reduce human exposure to this important pathogen have been infrequently addressed. CDIs have traditionally been assumed to be restricted to health-care settings. However, recent molecular studies indicate that this is no longer the case; animals and foods might be involved in the changing epidemiology of CDIs in humans; and genome sequencing is disproving person-to-person transmission in hospitals. Although zoonotic and foodborne transmission have not been confirmed, it is evident that susceptible people can be inadvertently exposed to C. difficile from foods, animals, or their environment. Strains of epidemic clones present in humans are common in companion and food animals, raw meats, poultry products, vegetables, and ready-to-eat foods, including salads. In order to develop science-based prevention strategies, it is critical to understand how C. difficile reaches foods and humans. This review contextualizes the current understanding of CDIs in humans, animals, and foods. Based on available information, we propose a list of educational measures that could reduce the exposure of susceptible people to C. difficile. Enhanced educational efforts and behavior change targeting medical and non-medical personnel are needed.
Introduction -why is Clostridium difficile relevant today?
First associated with disease in humans in the mid-1970s, Clostridium difficile is a spore-forming bacterium that produces major toxins responsible for mild-to-severe forms of gastrointestinal infections in most mammals. Severe C. difficile infections (CDIs) in humans have steadily increased in hospitals, and alarmingly in the community, over the past three decades, especially among elderly over 65 years old (Freeman et al., 2010) .
Because the life expectancy in humans and the proportion of elder citizens will rise globally (United-Nations, 2007), more CDIs are expected to occur in the future. Correspondingly, health-care costs associated with treatment are also expected to increase over time. Currently, the USA spends over $1.1 billion treating over half million CDIs every year.
To date, research has vastly focused on disease diagnosis, treatment, and control in hospital settings (Cohen et al., 2010; Barbut et al., 2011) , but very little has been reported on prevention at the community level. Unlike in hospitals, younger individuals, pregnant women, and children have emerged as susceptible groups in the community since the mid-2000s (Barbut et al., 2011) . In addition, individuals with inflammatory bowel diseases (IBD; i.e. Crohn's disease and ulcerative colitis), who mostly suffer life-long immune-mediated chronic recurrent gastroenteritis, have increasingly experienced more complications and mortality due to superimposed CDIs (Nylund et al., 2011) . In IBD patients (more than 1.4 million in the USA), who are often treated as outpatients (in the community), CDI can be seen in as many as 10% of IBD patients seeking hospital medical attention. Infection without prior healthcare contact or antibiotic exposure is common in IBD patients. Currently, there are growing concerns that IBD flare ups can be due in part to CDIs. Although there were earlier indications that C. difficile could be contributing to IBD, traditionally patients were not screened for CDI, because earlier studies found no association with C. difficile (Goodhand et al., 2011) . Treatment of IBD superimposed with CDI is becoming increasingly problematic, especially among adults with ulcerative colitis, and children who are increasingly likely to have concurrent CDIs (OR=11.42; 95% CI, 10. 16-12.83 ) (Nylund et al., 2011) .
Outside hospitals, it is known that certain environments, animals and foods are predictable sources of C. difficile (Gould and Limbago, 2010; , but this growing body of literature remains poorly communicated to health care professionals and the public in general. To date, no CDI cases have been confirmed to be of zoonotic or foodborne origin. Nevertheless, an increasing number of studies have shown that C. difficile with the toxins and potential to cause disease can often be found in animals, recreational waters, and raw and ready-to-eat foods, in variable frequencies (i.e. 0-66%) (Rodriguez-Palacios et al., 2012 ; C. difficile capable of producing toxins (which cause intestinal lesions) has been isolated from at least 70.3% (26/37) of food groups (representing independent studies and over 3519 food items) tested with enrichment methods in Europe and North America (see RodriguezPalacios et al., 2012 for a review) . The discrepancy between studies that isolate C. difficile and reports with 0% prevalence can be due to culture method choice (i.e., use of selective enrichment), and the increasingly recognized effect of spore age, superdormancy, thermoresistance, and sample refrigeration on our ability to detect C. difficile (Rodriguez-Palacios and LeJeune, 2011; Thitaram et al., 2011 , Kho, 2012 , Limbago et al., 2012 .
Although it is difficult to predict if a given food item, animal, or water source will have sufficient C. difficile (if any) to make someone sick, it is more feasible to predict who are the most susceptible individuals so as to educate and protect them. Although C. difficile may be introduced into health-care centers (hospitals/nursing homes) via the hands or clothing of new patients (both symptomatic and asymptomatic), visitors, or healthcare workers themselves, next generation whole genome sequencing has shown that patients during CDI outbreaks are getting ill with C. difficile strains that cannot be explained by personto-person transmission alone (Eyre et al., 2012) . Strains affecting people appear to be coming from outside healthcare centers. A recent study of C. difficile in the skin of people in two community settings in the USA and Ireland showed that it is more likely to be exposed to foods, which have the potential to carry C. difficile (up to 42%) than to be exposed to animals, recreational waters, hospitals settings, or to C. difficile on unwashed hands (<0.7%) (RodriguezPalacios et al., unpublished data) . Even the general ward environment of community hospitals has relatively low prevalence of C difficile (2.4%) (Faires et al., 2012) compared to some food groups (Rodriguez-Palacios et al., 2012) .
History and disease burden
Financial and social costs CDI is a costly disease in most countries. In the USA, estimates indicate that there are about 500,000 CDIs every year, which result in $1.1-3.2 billion in health care costs every year (O'Brien et al., 2007) . On average, each new CDI infection costs $3000-5000, whereas recurrent infections (more difficult to treat) cost $13,000-18,000 (Dubberke and Wertheimer, 2009; Ghantoji et al., 2010) . Similar high treatment costs have been documented in Europe (Wilcox et al., 1996; Ghantoji et al., 2010) .
With an increase in the number of human infections, there has also been an increase in social concerns. Over time the incidence of severe disease has increased with more patients requiring surgical removal of the inflamed colon (one in every ten CDI cases -10%), higher mortality rates, and concern about increased liability Sailhamer et al., 2009; Marler, 2010) . The effects of such medical consequences at the individual and family level are difficult to quantify. Infection control and surveillance initiatives have thus been reinforced in hospitals to reduce the incidence of C. difficile (Pepin et al., 2004; Barbut et al., 2011) with variable success.
Given that C. difficile also infects animals, the disease can have a financial impact on companion animals and livestock also. Financial loss estimates associated with CDI in animals are not available. However, in horses and other companion animals where C. difficile causes enteric disease, the costs associated with veterinary medical treatment are high (several thousand dollars in North America) and generally assumed by the owners. In livestock production, no estimates are yet available either, although there is evidence that C. difficile causes disease and possibly growth delays in production animals (Songer, 2004; Kiss and Bilkei, 2005) .
Early history of C. difficile as a gut pathogen C. difficile is a spore-forming anaerobic bacterium that was first isolated from stools of healthy infants in 1935 (Bartlett, 2008) . Although these first bacterial isolates were fatal to hamsters, no attention was directed to the health risks of C. difficile in adults until decades later; C. difficile was deemed normal in the gut of children. In 1962, the same bacterium was isolated from localized infections (e.g. wounds and abscesses) in adults (Smith and King, 1962) . Although these isolates were also fatal to hamsters, the authors concluded that C. difficile was not pathogenic for man.
Only in the late-1970s, additional studies in humans and hamsters confirmed C. difficile as the cause of a severe form of colitis in adults known since the 1890s as pseudomembranous colitis (PMC) (Bartlett, 2008) . In PMC, marked inflammation and cellular debris accumulate over the intestinal surface giving the appearance of a pseudomembrane. Microscopically, PMC was characterized by exuberant inflammatory plaques formed on the surface of the colon protruding from the intestinal wall (Price and Davies, 1977) . In humans, the cause of PMC was unclear for almost 80 years, until the 1970s when the administration of antibiotics, especially clindamycin and lincomycin, was linked to PMC (Tedesco et al., 1974) . Initially researchers thought that PMC resulted from a viral infection and the concurrent use of antibiotics (Steer, 1975) , but finally C. difficile was identified as the microbial cause secondarily linked to antibiotic use; which disrupts the gut flora favoring the opportunistic proliferation of C. difficile (Bartlett et al., 1978; George et al., 1978; Larson et al., 1978) .
Currently, PMC is almost always (>95%) linked to C. difficile (Hurley and Nguyen, 2002) , but not all CDIs result in PMC. In animals, a similar form of inflammation has been reported in a small fraction of piglets infected experimentally with C. difficile. In other animals (e.g. mice, hamsters, horses and calves), various forms of colitis have been described, from mild in most species to severe and fulminant in some horses (Colitis X, first case report was linked to an emerging hyper-virulent C. difficile PCR ribotype 027/NAP1 strain known to be highly problematic in humans) .
During the last decade, the severity of the CDI, including PMC, has increased in populations of children who were previously rarely affected. Today the growing epidemic and the more frequent lack of response to conventional therapies have raised the awareness of CDI to the point where it is increasingly recognized as a global public health challenge, often surpassing the importance of methicillin-resistant Staphylococcus aureus infections .
C. difficile in hospitals and risk factors
CDIs were first seen as sporadic cases in humans, particularly in hospitals, but in the 1990s, the frequency increased (>2-fold) as highlighted in an article entitled C. difficile: a pathogen of the nineties (Riley, 1998) . The problem has been especially notorious in developed nations (Pepin et al., 2004) , and continues to extend into the 2000s; now it has been documented in community settings ( Fig. 1) (Borgmann et al., 2008) . Controlling for confounding variables, it is known that such increase is not due to reporting bias (Burckhardt et al., 2008) . Other studies have also shown the remarkable parallel between the increased trend of disease in hospitals and the community (Noren et al., 2004) . However, the incidence of CDI is much lower (1300-fold) in the community, compared to hospitals, due in part to a lower (37-fold) occurrence of antimicrobial consumption (Noren et al., 2004) . Compared to other drugs, mortality data associated with drug consumption in the USA showed that among diseases with significant drug-related etiologies, C. difficile enterocolitis primarily associated with antimicrobials had the largest percentage increase in total mentions, with a 203% rise between 1999 and 2003 (Wysowski, 2007) . Today, the increased resistance to many antimicrobials, especially fluoroquinolones has become an emerging global health issue (Spigaglia et al., 2008; Ashiru-Oredope et al., 2012) . Among cases with antimicrobial-associated diarrhea, CDIs account for about 25-30% of all cases. For decades, antimicrobial consumption has been the main predisposing factor for CDI.
Elderly over 65 years old have been always more susceptible to infections (Pepin et al., 2004) . Regarding the source of infection, by the end of the 1990s, humans were considered to be the sole reservoirs for infection to other humans (Kaatz et al., 1988) . However, studies from the 1980-1990s outside hospitals in the UK demonstrated that C. difficile was present in water bodies in connection with urban settings, soils, root vegetables, and household pets (Borriello et al., 1983b; al Saif and Brazier, 1996) . The potential for animal-human and foodborne transmission was then highlighted. Although genetic testing of recovered strains determined that most isolates were capable of producing toxins (necessary for intestinal disease), no molecular typing was reported to determine if they were the same strains affecting humans.
The increasing number of cases inside hospitals maintained the attention on human-to-human transmission, mediated by environmental contamination of the hospital wards and health care personnel (Kaatz et al., 1988) . Infections originating in the community, where patients acquire CDI outside hospitals, were considered infrequent and received no attention for disease prevention. No connection or differentiation was acknowledged between community-and hospital-acquired CDI until the last decade. Currently, there are more defined criteria to classify new CDIs as community-or hospital-associated cases based on the site of acquisition or onset of clinical signs (Kuijper and van Dissel, 2008) . A similar differentiation has importantly been used in epidemiological studies in veterinary hospitals since the mid-2000s, especially in Canada .
Despite the rapid recognition of increased virulence and ecological aspects of C. difficile, medical textbooks continue treating C. difficile as the traditional medical condition acquired only in people exposed to hospitals or long-term health care settings with little attention focused on ecology and prevention. In veterinary medicine, C. difficile is still invariably reported in reference medicine books as an organism associated with clinical disease in animals, with limited emphasis on public health. Most veterinary literature largely remains as review articles.
Although several risk factors for CDI have been identified for humans over the past decades (see Table 1 ), it is noteworthy to highlight that the ages at which people get CDI (and possible exposure to other unknown risk factors) are parallel but significantly different in hospitals compared to the community. Younger individuals (although less likely to suffer CDI than the elderly) are comparatively more often affected in the community (Hirshon et al., 2011) . The distribution of ages of CDI patients depicted in Fig. 2 highlights that in hospitals most inpatients are significantly older when compared to the age of outpatients treated by the same center during the same period. Regarding the traditionally known risk factors (Table 1) , the following excerpt illustrates that disease trends are changing: 36% of patients had no history of antibiotic use within 3 months before symptom onset, and 25% had no underlying medical condition or recent hospital admission and, moreover, were younger than 45 (Kuijper and van Dissel, 2008; Hirshon et al., 2011) . CDI can no longer be considered a disease exclusively acquired in hospitals.
Age is a very important risk factor for disease. Although cases can occur in children elderly are more prone to CDI. Recent studies in long-term care facilities showed that over 50% of patients develop CDI beyond the fourth week after hospital discharge, much longer than for acute-health care settings, highlighting the importance of long-term disease prevention (Pawar et al., 2012) . In the community, cancer patients, Crohn's and ulcerative colitis patients, and other individuals receiving immunosuppressants and antibiotics are at risk for CDI. In humans, between 20 and 27% of CDIs that require hospital-level medical treatment are acquired in the community. Based on risk factors known (Table 1) , prevention measures could be focused on susceptible individuals.
Theory of person-to-person transmission disproved
The concept of hospital clonality, long suspected to be caused by a single highly infectious strain with clonal dissemination within hospital wards based on fingerprinting qualitative typing techniques, has been increasingly questioned for CDI. Using the latest portable sequencing technology, early in 2012, a whole-genome sequencing study of C. difficile isolates from cases assigned to three hospital outbreaks in UK demonstrated that most consecutive CDIs were due to different strains and so (in their own words) refuted the theory of person-to-person transmission to explain the increase incidence of CDI within hospital wards (Eyre et al., 2012) . For one cluster of CDI involving three people, over 4 days in the same ward the authors concluded that next generation sequencing refutes transmission between suspected linked cases and that isolates of the same strain type are not necessarily linked by person-to-person transmission. Data from this and two other clusters demonstrated that person-to-person transmission within hospitals is not as exclusively high as previously thought. Clostridium difficile strains appear to be introduced to hospitals by incoming patients (and possibly foods/visitation animals) more commonly than earlier suspected.
CDIs and toxin types
Numerous reviews describing the biology and epidemiological changes of CDI in humans are available. In animals, similar papers have been published since the first review describing C. difficile as an emerging pathogen in food animals in 2004 (Songer, 2004 (Songer, , 2010 Gould and Limbago 2010; Weese, 2010; RodriguezPalacios et al., 2012) . All reviews indicate that animals and foods are reservoirs of C. difficile strains that produce toxins. From experimental studies in animals, it is possible to say that CDI occurs only when C. difficile opportunistically proliferates in the intestinal tract of its host (animal or human) and produces its toxins that are deleterious to the intestinal wall. In this context, several factors are needed including: (1) the ingestion of C. difficile spores and the persistence of C. difficile in the intestinal tract, (2) the proliferation of C. difficile and the production of toxins in the gut, and (3) an immunologically susceptible host with disarranged gut flora.
Soon after its identification as a pathogen it was determined that the pathogenicity of C. difficile, was mediated via two similar, but structurally and immunologically distinct, virulence factors: Toxins A and B (Bongaerts and Lyerly, 1997) . Once in the cell, these toxins affect glycosylate Rho GTPase, a key enzyme in signaling pathways regulating actin polymerization. The net effect is a disruption of normal cytoskeletal architecture leading to cell death followed by local and systemic inflammatory reactions (Mazuski et al., 1998; Hamm et al., 2006; Sun et al., 2010; Modi et al., 2011) . Another toxin, called binary toxin, present in a fraction of C. difficile strains may also contribute to disease (Geric et al., 2004 (Geric et al., , 2006 Terhes et al., 2004; Stare et al., 2007; Schwan et al., 2009; Sun et al., 2010) .
Almost always, strains capable of causing disease carry both the toxins A and B, denoted A + B + . However, since 1999, naturally occurring C. difficile mutant strains, lackng toxin A (A À B + ), have caused major outbreaks in hospitals internationally (al-Barrak et al., 1999; Loo et al., 2005; Lyras et al., 2009; Kuehne et al., 2010; Sun et al., 2010) . In the past, A À B + strains were uncommon (<5%); nowadays, those strains are problematic and predominant (>30%) in certain regions (Kim et al., 2008; Shin et al., 2008a, b) . Since the strains that do not produce either toxin A or toxin B (A À B À ) are non-pathogenic (Bongaerts and Lyerly 1997; Rupnik et al., 2005) , there has been interest in therapeutic microbiology using these strains as probiotics to prevent colonization in susceptible hospitalized people. Experiments in various animal species support the potential benefit. Noteworthy, non-toxigenic strains (A À B À ) are comparatively more common in mature food animals than in people and foods, but A À B+ in foods appear to be less common (Bakri et al., 2009; .
In addition to toxin-based studies, the advent of genomics and systems biology have spurred the increasing documentation of other possible virulence factors since the early 2000s. Therapeutically, such knowledge still has not yet resulted in new effective measures to treat CDI in hospitals. Immunologically, most high risk or severely ill patients have low levels of antibodies against toxins A and B, while healthy individuals appear to have higher titers (Kelly and Kyne, 2011) . Therapeutic interest is now in the use of antibody supplementation to currently approved therapies against CDI, largely based on antimicrobials against C. difficile, i.e. metronidazole and vancomycin, and DNA based vaccines against toxins A and B (Jin et al., 2013) . However, increased resistance to such antimicrobials is also increasing (Sinh et al., 2011) . Patented human monoclonal antibody technology is in phase clinical trials. Thus far, the therapeutic benefit seems to be present when antibodies are supplemented in mild-moderate cases; but the response is poor in severe CDIs. Epidemiological and experimental data indicate that immune susceptibility and bacterial flora disarrangements are major factors for CDI. Aside from reinforcing hand washing, little has been done on actively involving the communities at risk to prevent exposure to C. difficile.
Increased antimicrobial resistance and ability to produce toxins
Compared to isolates from before 2000, current C. difficile isolates affecting people are more resistant to antibiotics (Warny et al., 2005; Sinh et al., 2011) . Further, some strains arguably can produce up to 16-to-20 times more toxins (A or B) in vitro compared to regular strains (Loo et al., 2005; Warny et al., 2005) . Therein, those strains increasingly isolated in current times are often referred to as 'hyper-virulent' strains (Mulvey et al., 2010) . The most widely factor associated with the increased ability to produce toxins in vitro is the presence of a genetic mutation in a gene (tcdC) that normally down-regulates the genes responsible for the production of toxins A and B. In vivo, the association of tcdC polymorphisms with disease severity is less clear. Other virulence factors such as antibiotic-induced adherence to intestinal cells (Deneve et al., 2008) and strain-dependent systemic toxin pathogenicity are possibly contributing features (Lanis et al., 2012) . Of public health relevance, hyper-virulent strains, associated with severe disease in humans, have been increasingly isolated from food animals and foods since 2006 (Rodriguez-Palacios et al., 2007a; .
C. difficile recurrences are increasingly common
Following recovery from a CDI, reinfections in the same individual and treatment failure are occurring with more frequency. Recurrences after treatment of CDI with metronidazole (first drug of choice) have increased from 7% before the year 2000 to 29% thereafter (Kelly and LaMont, 2008; Sinh et al., 2011) . Although not everyone suffers reinfections, some individuals are overly sensitive. The reasons for such susceptibility are currently under investigation. Low antibody titers effective against the C. difficile toxins (Wilcox, 2004) , and disrupted intestinal flora due to antimicrobials ) are among the factors that enhance susceptibility to reinfections. Increasingly, the administration of proton pump inhibitors (widely prescribed antacid) confers more risk for recurrence compared to other classes of antacids (Linsky et al., 2010) . More common since the year 2000, reported rates of reinfections have varied between 15 and 30%, with recurrences commonly seen among elderly (Kelly and LaMont, 2008) .
The more recurrences a person has, the more likely he/ she is to have a recurrence again. The risk of recurrence goes from about 20% after the initial CDI episode to about 40 and 60% after the first and two-or-more recurrences, respectively (McFarland, 2008) . In at least 10% of cases, subsequent infections are caused by a new C. difficile strain that is molecularly different from that of the first CDI episode (Wilcox et al., 1998; Noren et al., 2004; Hell et al., 2011) . As more discriminatory typing methods become available (e.g., multiple-locus variable number tandem repeat analysis, MLVA; or next generation sequencing) (Marsh et al., 2011; Eyre et al., 2012) , it is likely that more recurrences will be recognized to be indeed due to different strains, and not due to persistent infections. Currently, reinfection with different strains indicates that there are unrecognized sources of C. difficile in the community that serve as the source of infection for convalescent people following hospital discharge. Numerous studies have shown that animals, foods, and recreational environments can be sources of C. difficile strains similar or identical to those causing diseases in humans (Janezic et al., 2012) . Table 2 summarizes reported sources of C. difficile in the community. Table 2 . Reported sources of C. difficile outside hospitals (in the community) Contaminated foods (difficult to predict/notice; variable; C. difficile has been found in food with good organoleptic quality). The prevalence ranges from 0 to 42%, although most studies have reported prevalences below 7% Healthy animals shedding C. difficile (difficult to predict/notice; animals look healthy). The prevalence can be as low as 0% in adult healthy animals, to 100% in young piglets. Diseased animals suffering CDI can shed C. difficile in feces (predictable, possible but unclear role in human disease; animal-to-animal transmission has been partly documented) Animal waste (occupational risk is possible but unknown; occupational risk has been documented for laboratory personnel taking antimicrobials and working with C. difficile carrying specimens). Contaminated environment (difficult to predict/notice unless obvious influence of potential source of C. difficile; for instance, sewage from human/animal facilities; C. difficile has been found in recreational waters).
Animals, the environment, and foods
In animals, the first studies reporting the isolation of C. difficile from companion animals and pigs were published in the 1980s. However, it was early in the 2000s when the association with enteric disease in animals was confirmed. Later, molecular fingerprinting comparing C. difficile isolates from companion animals and humans indicated for the first time the potential for identical strains to share human and animal habitats . As an environmentally stable microorganism, transmission from animals to humans may occur via exposure to contaminated environments.
Although the possibility of animals being reservoirs of C. difficile relevant for CDI had been suggested for years, it was not until the mid-2000 that molecular evidence became stronger while studying food animals. A large microbiological survey conducted in dairy calves documented the etiological role of C. difficile in bovine neonatal diarrhea in ill calves after controlling for other pathogens; and the presence of epidemic human strains of international relevance (PCR ribotypes 078, 027, 014, and 017) in healthy calves (Rodriguez-Palacios et al., 2006; Rupnik, 2007) . Subsequently, C. difficile was recovered from ground meats (Rodriguez-Palacios et al., 2007a ), which appears to have a reproducible seasonal pattern that matches that of bovine, swine, and human CDIs in North America (Rodriguez-Palacios et al., 2009 ) (see seasonality section below). Noteworthy is to mention that depending on the environment, not all animals carry C. difficile (Bandelj et al., 2011; Rodriguez-Palacios, 2011) . Predicting which animals are carriers is becoming less challenging as knowledge increases. This is important for prevention given growing indications of potential zoonotic transmission for some C. difficile strains, namely PCR ribotype 078; see for a review on behalf of the European Society of Clinical Microbiology and Infectious Diseases Study Group for C. difficile.
Companion animals -household pets
In modern times, especially in urban areas, pets are an integral part of the family, sharing human lifestyles, bedrooms, and beds. Recent estimates indicate that between 14 and 62% of pet owners allow dogs and cats on their beds (Chomel and Sun, 2011; Montgomery et al., 2011) . Although dogs and cats have been shown to carry toxigenic strains of C. difficile in their feces since the 1980s (Borriello et al., 1983b) , the current striking genetic similarity between isolates from animals and humans indicate that zoonosis may be occurring (Lefebvre et al., 2006) . Most companion animals that harbor C. difficile do so asymptomatically (Weese et al., 2010a) . However, if risk factors are prevalent, that parallel those of humans (antimicrobial administration), dogs and cats may develop diarrhea (Weese et al., 2001) . No PMC or C. difficile bacteremia has being documented in dogs or cats.
Screening studies indicated that up to 10% of household pets may carry C. difficile, representing a risk for owners (Weese et al., 2010a) . Although no direct transmissibility from pets to humans has been documented, the presence of virulent strains of C. difficile (including PCR ribotype 027) in 'therapy' dogs indicate that in hospitals, visitation animals might carry strains within and outside health-care facilities (Lefebvre et al., 2006) . Pets owned by an immune-compromised person are more likely to be colonized by C. difficile (Weese et al., 2010a) . However, in one study that examined the zoonotic risk, the strains isolated from dogs and households were different (Weese et al., 2010a) another indication against direct-contact transmission. Although the authors concluded that dogs were not a significant source of household C. difficile contamination, all isolates from dogs were indistinguishable from historical isolates recovered from ill humans in the same geographical region, including emerging PCR ribotype 027. Therefore, it is advisable to prevent close contact between susceptible people and pets with diarrhea. It is also important to highlight that inadvertent infections with C. difficile (or other enteric human pathogens) in healthy-looking pets could occur in association with the consumption of raw pet foods Finley et al., 2006) . Avoiding the inclusion of raw meats in pet diets is always a good practice to reduce the risk of transmission of C. difficile and other zoonotic pathogens, especially if high-risk individuals are in the household.
In veterinary hospitals, outbreaks of severe diarrhea associated with C. difficile have been reported in small animal clinics (Weese and Armstrong, 2003) . Therefore, pets may become inadvertent carriers of C. difficile spores following routine veterinary visits or hospitalization. To date no studies have assessed the potential of dogs and cats to be vehicles of C. difficile strains out of veterinary hospitals and within food or livestock production systems.
Companion animals -horses
C. difficile has also been studied in horses since the mid1980s (Ehrich et al., 1984) . Today, it is known that in the community up to 7% of healthy horses can carry C. difficile (Medina-Torres et al., 2011), but the proportion of animals shedding the pathogen varies across studies as it depends on culture methods, the animals' age, and management conditions. Adult horses are less likely to carry the bacterium compared to neonatal foals. Overall, between 2 and 30% of horses were found to be carrying spores at any given time without showing signs of disease (Baverud et al., 2003) . However, like other species, horses can also develop diarrhea and forms of serious colitis Songer et al., 2009) . As in humans, antimicrobials increase the risk of horses being affected with CDI . In young foals, antimicrobials are also a predisposing factor (Arroyo et al., 2004) . Co-infection with C. perfringens may explain enterocolitis in some foals (Uzal et al., 2011) . In equine hospitals, strict isolation and infection control measures are thus widely recommended to avoid outbreaks (Baverud, 2004) .
Some ethnic societies by tradition still rely on horse power to work agricultural lands to produce foods, especially fresh produce (Lengacher et al., 2011) . In many regions, regulated production and slaughter of horse meat is allowed to sustain, at least partially, local economies and traditions (USDA, 1997). Since horse manure can contain C. difficile spores for years (Baverud et al., 2003) its use as traditional organic fertilizer highlights the risk for fresh produce contamination (Pell, 1997) . To date, there are no studies addressing the role of horses in food and environmental health and safety associated with C. difficile. Nevertheless, farmers and animal handlers should be aware of the risk of finding C. difficile on horse manure and the potential for dissemination to susceptible members of the family or the community.
Food animals -pigs
As in companion animals, C. difficile was also isolated from pigs in the early 1980s (Jones and Hunter, 1983 ). Since then, over 60 published studies have served to now recognize C. difficile as an enteric pathogen in this domesticated species. Among pigs, young piglets have the highest risk for disease development (Post et al., 2002) . For this reason, pigs have been increasingly used as models to study the pathogenesis of this disease Songer, 2007, 2011; Steele et al., 2010; Scaria et al., 2011) . Mortality and morbidity rates in pigs are largely uncertain, but some estimates indicate that up to 100% of litters and individual piglets can be affected in infected farrowing facilities (Songer, 2004) . In non-fatal cases, weaning weights of diseased pigs can be 10% below the expected average weight (Songer, 2004) . In older animals, there is one report of an association between C. difficile and increased mortality in sows that received antimicrobial treatment (Kiss and Bilkei, 2005) .
During processing, the isolation of C. difficile from healthy pigs close to the harvest time, and from processed carcasses (<2.5%) support the potential for food contamination (Norman et al., 2009; Weese et al., 2011 , Susick et al., 2012 . Recent isolation of C. difficile from mesenteric lymph nodes at harvest (<1%) indicates that pathogen dissemination from the gut to muscles tissues via the circulatory and lymphatic system is possible (Susick et al., 2012) .
Swine-derived C. difficile isolates have garnered the greatest attention from public health personnel because PCR ribotype 078 -the increasingly documented emerging human strain in the community -is the major strain among porcine isolates. PCR ribotype 078 isolates have accounted for up to 80% of all swine isolates in most studies involving pigs in North America and Europe Debast et al., 2009; Songer et al., 2009) . In humans, the same strain has increased its association with human disease by at least 6-fold from 2000 to 2008 (Goorhuis et al., 2008) . Regarding the type of production system, no differences have been found between the prevalence of C. difficile in organic and conventional swine operations (Keessen et al., 2011) , or between conventional and antibiotic-free operations (Susick et al., 2012) .
Food animals -cattle
Until recently little attention was directed to the study of C. difficile in ruminants. The first published report described C. difficile in veal calves with diarrhea in 2002 (Porter et al., 2002) . The first published study quantifying the impact of C. difficile in the bovine industry determined in 2004 the role of the pathogen as a cause of diarrhea in young calves, the effect of seasonality, and its implications for public health (Rodriguez-Palacios et al., 2006) . In that study, a case-control study of calves <28 days of age -from 102 dairy farms in Canadashowed that significantly more calves with diarrhea were positive for C. difficile toxins compared to the control group, suggesting an association of C. difficile with intestinal disease. In further experimental studies, the same group could not induce disease when calves fed colostrums were given orally high numbers of toxigenic C. difficile (Rodriguez-Palacios et al., 2007a, b) . Subsequent studies in calf ranches have supported the association of intestinal lesions with C. difficile (Hammitt et al., 2008) . Colonization of neonatal calves infected under natural conditions was detected within 24 h of birth and lasted for at least 6 days after detection, indicating that calves were indeed amplifiers of toxigenic C. difficile (Rodriguez-Palacios et al., 2007a) . Histological lesions were mild and restricted to ileum and colon. In veal calves, the rate of C. difficile shedding and associated diarrhea increases as animals are treated with antibiotics upon entry to finishing operations (Costa et al., 2011) . Strain clonal diversity and shedding prevalence in young farm animals decrease with age (Rodriguez-Palacios et al., 2006; Zidaric et al., 2012) .
In older cattle, C. difficile shedding decreased over time during the finishing period and was not affected by the administration of antimicrobials (Rodriguez-Palacios et al., 2011b) . At the time of harvest, C. difficile can be found in healthy feedlot steers and culled dairy cattle, highlighting the risk for carcass and food contamination (Rodriguez-Palacios et al., 2011a, b; Thitaram et al., 2011) . In Belgium, the frequency of shedding at slaughter was about 7% . Younger cattle used for food production, i.e. veal calves, although representing <2% of all meat consumed in the USA, can also have C. difficile strains of relevance for disease in humans (Costa et al., 2011; Houser et al., 2012) . Regardless of its association with enteric disease, C. difficile isolates derived from cattle were the first to draw attention to the potential for foodborne transmissibility involving current epidemic human strains PCR ribotypes 017, 027, 077, 014, and 078 (Rodriguez-Palacios et al., 2006 , 2012 Hammitt et al., 2008 ) (Compare Fig. 3 and 4) . Antimicrobial resistance against new-class linezolid, but not tigecycline, has been observed in C. difficile from cattle at harvest in the USA (RodriguezPalacios et al., 2011a) .
Food animals -poultry
This is the food animal species that has been studied the least. The first studies that highlighted the potential relevance of poultry as carriers of toxigenic strains are from Africa (Simango, 2006; Simango and Mwakurudza, 2008) . In Zimbawe, Simango and colleagues showed that up to 30% of free-range chickens carried toxigenic C. difficile with antimicrobial resistance patterns of relevance for humans (Simango, 2006; Simango and Mwakurudza, 2008) . These results indicate that the risk of transmission via foods/animals to susceptible people in Africa, where the rate of HIV-infected patients in the community at risk for CDI is high (Onwueme et al., 2011) , might be a relevant factor to consider for targeted intervention. The prevalence of C. difficile in free range poultry in Zimbabwe could be extrapolated to comparable societies where free range poultry is common practice including some Asian and Latin American countries where C. difficile has been problematic in humans (Legaria et al., 2003; Rupnik et al., 2003; Huang et al., 2008; Balassiano et al., 2012) .
Recent studies on poultry commercial operations have also documented the relevance of C. difficile in Europe and North America, where free-range production contributes less to the food supply. In Slovenia, one study conducted on an intensive commercial farming system reported that the percentage of birds colonized with C. difficile was higher than that reported in African freerange poultry, with prevalence decreasing with age (Zidaric et al., 2008) , as shown in calves, other animals, and children (Rodriguez-Palacios et al., 2006; Enoch et al., 2011) . In that study, over 60% of birds carried C. difficile in early production, but it was significantly less frequent (below 2%) as animals approached harvest time. In Austria, 5% of poultry tested had C. difficile (Indra et al., 2009) . In agreement, the percentage of poultry and turkey colonized at harvest in the USA approached zero in intensive rearing facilities in Ohio (Rodriguez-Palacios et al., unpublished data) . More recently, the prevalence of C. difficile in commercial chickens was also comparable at 2% prior to harvest in Texas in a study conducted by the U.S. Department of Agriculture (Harvey et al., 2011) . Clearly, much more work needs to be done in this field also, especially because, inexplicably, the prevalence of C. difficile in poultry meats, at least in North America, is significantly higher postharvest, ranging between 6 and 12% of chickens (Weese et al., 2010b; Harvey et al., 2011) . Considering that Campylobacter illnesses in humans are often associated with the consumption of poultry (Moran et al., 2009; Scallan et al., 2011) , it is possible that the risk of infection with C. difficile via ingestion of contaminated foods is comparable, simply because spores are expected to be more resistant to heat than the vegetative and viable but not culturable forms of Campylobacter spp.
In summary, from the available reports of C. difficile in animals, two general conclusions can be drawn. First, similar to humans, newborn and young animals are more frequently colonized by C. difficile than adult animals; however, unlike humans neonatal animals are at higher risk of being affected with enteric disease. Second, also similar to humans, animals in most studies exhibit a small diversity of C. difficile strains, although the high strain diversity observed in some cattle and poultry studies (Rodriguez-Palacios et al., 2006; Zidaric et al., 2008; Avbersek et al., 2009) factors are possibly contributing to the selection of a few predominant strains.
Waters and the environment
In general, spore-forming bacteria including clostridia are microorganisms that last a long time in the environment. With very few exceptions, C. difficile produce spores that can survive for months in the environment (Baverud et al., 2003) , but not many publications are available in this regard. A British publication described the presence of toxigenic C. difficile in soils, wells, recreational waters, veterinary clinics, and in households (al Saif and Brazier, 1996) . In Africa, soils in rural areas of Zimbawe inhabited by free-range chicken also had toxigenic C. difficile (Simango, 2006) . Despite these publications, little attention has been placed on the environment as a source of infectious spores and on its role in human and animal infections. C. difficile spores are disseminated via air in indoor environments (Roberts et al., 2008 ) (see Dissemination below). At the farm level, this area of research remains largely unexplored.
C. difficile in foods
Discovering that a particular microorganism becomes an emerging food safety concern should not be surprising. Foods have been a historic source of exposure for many pathogens. However, despite the expectedness of such an event, skepticism is natural. C. difficile was first recovered from foods and animals in 1980. In 1982, it was suspected as the cause of PMC that occurred after an elderly patient consumed canned salmon (Gurian et al., 1982) . However, the patient had other health issues (hypochloremia) and the food item was not cultured. During 1981 During -1983 , two studies reported finding no C. difficile in cooked foods from hospital menus; but the studies did not acknowledge that fresh foods or undercooked foods could be a source of exposure. It is important to note that culture methodology for food and environmental samples might have been suboptimal at the time since concurrent sampling of hospital air and walls yielded no C. difficile in the same studies. Further discussion about potential foodborne transmission went on until 1983 (Borriello et al., 1983a) . Fig. 4 . Frequency of isolation of toxigenic C. difficile of distinct PCR ribotypes from humans, young cattle, and various foods. Note the relative importance of food animal derived strains in cases of human disease, and the presence of some ribotypes in Europe and North America (i.e., PCR-078). Data compiled from Rodriguez-Palacios et al., 2006; Bauer et al., 2011; Reil et al., 2011; In retrospect, we now know that thorough cooking (at least 96 C, 15 min) should eliminate the amount of C. difficile expected to be found in most foods (RodriguezPalacios and LeJeune, 2011) . During the 20-year period 1982-2002, there was only one publication on C. difficile and foods. It was a report of an incidental finding of C. difficile in packed meats published by Broda et al. (1996) .
Raw and ready-to-eat foods
Raw ground beef and pork were among the first food products to be found contaminated with C. difficile. In 1994, Broda and her colleagues, studying microorganisms that caused gas 'blown pack' spoilage in ready-to-eat meats incidentally found C. difficile (Broda et al., 1996) . The next study conducted on raw meat commercial diets for dogs and cats also found C. difficile in a sample of turkey-based diet . Despite the frequent occurrence of C. difficile in foods, its public health significance has generally been under-recognized or viewed with skepticism. A specially designed study base on MLVA have highlighted that the isolation (and prevalence) of C. difficile in the food supply is real and not due to laboratory contamination of the food samples (Curry et al., 2012) .
In 2007, the first study documenting human epidemic strains of C. difficile in foods (specifically, in 20% of retail ground meats), documented the regional and international relevance of the finding (Rodriguez-Palacios et al., 2007a) . Subsequent studies have confirmed that this pathogen can be found in other foods tested. Now, scientific reports describe toxigenic C. difficile in meats in several countries. Although the percentages of meat packages that have been contaminated with C. difficile have ranged from 3 to 42%, the overall expected real prevalence of C. difficile contamination under natural conditions at the store level (by sampling 1-2 retail packages of meat per store) has been determined to be at about 6% (Rodriguez-Palacios et al., 2009) . Poultry has been the type of meat least studied. One study found no C. difficile in retail poultry (Indra et al., 2009) ; however recent studies indicate that poultry meats can also carry toxigenic strains (Weese et al., 2010b; Harvey et al., 2011) . In the USA, the frequency of contamination of retail chicken has been documented to be between 9 and 18%, with all the edible animal parts (legs, wings, thighs, etc.) having comparable frequencies of contamination (Weese et al., 2010b) . Of concern, emerging C. difficile PCR ribotype 078 strains was found in retail chicken in both Canada and the USA (Weese et al., 2010b; Harvey et al., 2011) . This strain is an emerging strain in humans, in hospitals, and the community, in food production environments and in retail foods . The earlier identification of C. difficile in animals, with the subsequent increase of incidence of PCR ribotype 078 among people with CDI over the last decade indicates that this pathogen strain is likely moving from animals to humans (Goorhuis et al., 2008; . At the processing plant, there is now molecular evidence to suspect persistence and potential cross-contamination of retail food (pork) products with unique MLVA types belonging to the PCR ribotype 078 clone over time (Curry et al., 2012) .
Convenient ready-to-eat products (deli meats and minimally processed fruits and vegetables) are gaining market share. Unlike other infamous foodborne bacteria, such as Escherichia coli O157:H7, the spores formed by C. difficile that are often found in these products are highly resistant to current recommended cooking food safety guidelines. Molecular studies confirmed in Scotland that ready-to-eat salads were contaminated with C. difficile strains linked to human disease (Bakri et al., 2009) . Clostridium difficile was first isolated from root vegetables in 1996 (al Saif and Brazier, 1996) . More recently, it has been isolated from vegetables in North America; (J. G. Songer, 2007, personal communication; Rodriguez-Palacios and LeJeune (2007) , unpublished data; Metcalf et al., 2010) . C. difficile have also been isolated from shellfish and fish, which are often consumed undercooked or raw (Metcalf et al., 2011) . In Europe, the highest rate of food contamination was reported last year in edible mollusks in Italy, 49% (Pasquale et al., 2012) . Several reviews are available summarizing the studies documenting C. difficile in foods (Indra et al., 2009; Gould and Limbago, 2010; Weese, 2010) . In Latin America, the first report is from Costa Rica, where a molecular clinical genotype was found in 2% of food samples; notoriously, the isolates were susceptible to the antibiotics to which the clinical isolates were highly resistant (Quesada-Gomez et al., 2013) . Unless proven otherwise, antimicrobial discrepancy between genetically related strains should not be used to deem two isolates as non-related (Eyre et al., 2012) .
Seasonality
As with many other diseases, there could be parallel in the seasonal trends in CDI associated with the prevalence of the causative bacterium in animals, foods and humans (Rodriguez-Palacios et al., 2009) . The number of cases of CDI in humans is higher during winter months, at least in northern latitudes (Burckhardt et al., 2008; RodriguezPalacios et al., 2009; Reil et al., 2012) . That seasonal increase has been partly attributed to a larger number of cases associated with seasonal respiratory and enteric viral infections that require antimicrobial administration or hospitalization (Polgreen et al., 2010) . In foods and food animals, at least three independent studies document the same seasonal pattern in North America (higher prevalence in winter) (Rodriguez-Palacios et al., 2006 Norman et al., 2009; Kho 2012) . Although seasonality patterns could occur independently in parallel as a function of climatic variations (Naumova et al., 2007) , it is also possible that the prevalence of C. difficile at least in food animals, some foods, and people could be epidemiologically connected. It is important to note that earlier studies did not identify seasonal patterns in human disease (Tvede et al., 1990) .
Together, the molecular characteristics and virulence markers of food and food animal-derived C. difficile isolates indicate that the presence of emerging strains in vegetables and meats (and possibly the seasonality) might have a direct, yet unproven, connection with the epidemiology of CDI in humans. Although confirming such a connection might take some time, there is enough epidemiological evidence to take action and enhance prevention through education to minimize the risk of inadvertent exposure to C. difficile among individuals at risk.
Irrespective of the type of food product tested, the most important and concerning finding is that emerging hyper-virulent strains of C. difficile (PCR ribotypes 027 and 078) are among the most predominant genotypes recovered from foods (Fig. 4) . The reasons for the predominance of these ribotypes are unknown, but increased sporulation rates could favor some strains (Akerlund et al., 2008) to become endemic in the environment.
Dissemination of C. difficile
More recently there have been growing concerns regarding biosecurity and further global dissemination (Clements et al., 2010) . Hyper-virulent strains of C. difficile that were first reported in humans and animals in Eastern North America and Western Europe in the early 2000s (Warny et al., 2005; Kuipjer et al., 2008) have been identified in sporadic cases and outbreaks of disease in humans in more distant locations, including Australia, Japan, Korea, and Singapore, since 2007 (Sawabe et al., 2007; Tae et al., 2009; Clements et al., 2010; Lim et al., 2011) . Transcontinental commercial flights and the importation of live animals from places where emerging strains are documented have been listed as possibilities for dissemination (Clements et al., 2010) of lineages that emerged in North America (He et al., 2012) . At the regional level, studies in white-tailed deer (common visitors to livestock grazing areas and abundant in North America, Europe, and New Zealand) and wild birds have been documented to be an important factor for C. difficile dissemination in a suburban agricultural region, with tangible exposure potential to humans and animals in the USA (Rodriguez-Palacios et al., unpublished data; French et al., 2010) . C. difficile has been isolated from several other wildlife species since the 1980s, including feral swine populations (Thakur et al., 2011) . Air dissemination studies have increased in recent years. Studies conducted around the vicinity of pig farms indicate that aerial dissemination for short distances is possible with downstream currents. In bathrooms, C. difficile has been found surrounding toilets, presumably due to aerosolization of fecal particles during flushing. Not surprisingly, this is of preventive relevance since seemingly identical C. difficile strains have been isolated from pigs and from toilets used by the farm workers in an integrated swine operation (Norman et al., 2009) .
Genome association studies
Whole-genome, microarray-based studies indicate that food animals might have been the original sources of some emerging epidemic strains of C. difficile, particularly newly emerging PCR ribotype 078 (Stabler et al., 2006; Goorhuis et al., 2008; Bakker et al., 2010) . MLVA analysis continues to indicate that hospitalized humans and food animals, and foods are carrying clonally related strains (Marsh et al., 2011; Koene et al., 2012) . However, no conclusive studies are available to determine if animal shedding or food contamination are associated with changing patterns of disease in humans. Rather, it is possible that the pathogen constantly moves between humans, animals, and the environment, partly evolving and adapting as it moves across temporal and spatial niches. Given the spore forming nature of C. difficile, it is possible that inter-species transmission occurs from environmental sources and that some level of host adaptation (Janvilisri et al., 2009 ) and clonality has also ensued in parallel over millions of years (Stabler et al., 2006; He et al., 2010) . Horizontal gene transfer and homologous recombination are very frequent genetic events in C. difficile. It is possible that the epidemiology of C. difficile will continue to evolve. Genomic approaches are increasingly used to understand virulence pathways and to provide modern alternatives for rapid diagnosis and treatment (Forgetta et al., 2011; Eyre et al., 2012) , but prevention strategies remain a challenge mostly due to limited information on disease ecology (outside hospitals) and inherent problems with integration of knowledge across disciplines. Addressing this issue, here we identify areas where recommendations should be expanded (Table 3) . We have also proposed a list of simple educational measures for prophylactic use, which is under multidisciplinary consideration.
Reducing risks by targeted prevention in the community
Many aspects of ecology and epidemiology of C. difficile are still unknown. Achieving an increased understanding of the factors that contribute to the survival and persistence of this organism in different environments is a critical step to enhance environmental health, food safety, and disease prevention. Reducing the presence of this pathogen at preharvest, harvest, and postharvest stages of food production will allow the 12 A. Rodriguez-Palacios et al.
development of science-based strategies to prevent food contamination. Meanwhile, if foodborne transmission of this important pathogen is significant, cooking, and hygiene measures to enhance the elimination or destruction of C. difficile spores from potentially contaminated retails foods or from areas where food is prepared could mitigate the incidence of human disease. Although no infective dose data are available for humans, the number of spores needed for infection is presumed to be small based on CDI hospital epidemiology and studies with animals. Considering that (1) immune-compromised laboratory mice require about two environmental C. difficile spores/cm 2 to become ill (Lawley et al., 2009) , (2) that contaminated foods carry 20 to 240 C. difficile spores per gram (Weese et al., , 2010b , and (3) that infected healthy animals shed between 1,000 and 10,000 spores per gram of feces , it is important to emphasize the need of new and expanded measures to reduce pathogen exposure (Table 3) , which is necessary for CDI induction. Not only would these measures impact the exposure to C. difficile complementing existing infection control guidelines (Gerding et al., 2008) , enhanced food hygiene and thorough cooking would also reduce illnesses associated with other enteric pathogens.
Recommending thorough cooking, kitchen hygiene, and minimize exposure To date, most food safety guidelines available to the community instruct people to cook most foods at determined minimum internal temperatures to achieve a significant (6 log units) reduction of major foodborne pathogens to make most meals safe. These ranges vary from 63 C to 74 or 85 C (CFIA, 2010; USDA, 2011) . Because recent quantitative studies have shown that C. difficile spores can survive extended heating at 71 C (160 F), the minimum temperature recommended for cooking of meats , it is necessary to heat foods at higher temperatures to inactivate C. difficile spores. Based on quantitative analysis with C. difficile isolates derived from foods, food animals, and humans (Meisel-Mikolajczyk et al., 1995; Rodriguez-Palacios and LeJeune, 2011) , heating foods to 85 C for 10-15 min could be a reasonable strategy to minimize the counts of C. difficile in foods. Alternatively, heating at 96 C (sub-boiling) could reduce 6 log 10 within 2-3 min (Rodriguez-Palacios and LeJeune, 2011) . Thorough cooking at boiling temperatures, a common household practice, is ideal, and could be emphasized. As C. difficile could still survive cooking temperatures and multiply in heated foods, it is also recommended that foods be properly chilled and stored as indicated for other clostridial foodborne pathogens.
Conclusion
C. difficile has been associated with disease in people since 1975, but recently the identification of emerging multidrug resistant hyper-virulent strains from animals and foods indicate that there is the potential risk for transmission and infection in humans, especially among high-risk populations. Since CDIs have been traditionally considered as hospital acquired diseases, little attention has been paid to the sources of infection and risk factors in the community. Community-onset CDIs as they are admitted to health care centers have the potential to influence the overall epidemiology of this disease. Although there are no scientific reports explicitly confirming that C. difficile can be acquired via foods or contact with animals, there is sufficient laboratory and epidemiological research data and the mechanistic rationale (i.e. principles of fecal-oral transmission of enteric pathogens) to propose and adopt interventions to prevent transmission. Understanding the risk factors associated with disease and the sources of C. difficile where the pathogen is acquired by food animals and by humans can assist in developing strategies to enhance food safety and protect human health. Prevention at various levels is especially important as the theory of person-to-person transmission is being reexamined. Hand washing -Requires emphasis for people at risk and for food/animal health professionals. Use of antimicrobials and antacids -Requires emphasis to target susceptible communities outside hospitals, and involvement of pharmacists.
Not existent, not publicized:
Contact precautions regarding human and animals with CDI, healthy pets and wild animals. Cleaning and disinfection -Addressing food, home, kitchen and laundry environments. Thorough cooking -Current food safety guidelines are ineffective against C. difficile.
